176 related articles for article (PubMed ID: 37884535)
21. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
[TBL] [Abstract][Full Text] [Related]
23. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.
Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G
Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762
[TBL] [Abstract][Full Text] [Related]
24. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
[TBL] [Abstract][Full Text] [Related]
25. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
[TBL] [Abstract][Full Text] [Related]
26. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on
Notohamiprodjo S; Eiber M; Lohrmann C; Weber WA
J Nucl Med; 2022 Nov; 63(11):1673-1676. PubMed ID: 35241484
[TBL] [Abstract][Full Text] [Related]
27. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B
Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190
[TBL] [Abstract][Full Text] [Related]
28. A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on [
Girard A; Dercle L; Vila-Reyes H; Schwartz LH; Girma A; Bertaux M; Radulescu C; Lebret T; Delcroix O; Rouanne M
Eur Radiol; 2023 Apr; 33(4):2821-2829. PubMed ID: 36422645
[TBL] [Abstract][Full Text] [Related]
29. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
[TBL] [Abstract][Full Text] [Related]
30. Discordant results in
Parisse-Di Martino S; Faure C; Mognetti T
Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
[TBL] [Abstract][Full Text] [Related]
31. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
32. Cervical ultrasonography has no additional value over negative
Goense L; Meziani J; van Rossum PSN; Wessels FJ; Lam MGEH; van Hillegersberg R; Ruurda JP
Eur Radiol; 2018 May; 28(5):2031-2037. PubMed ID: 29218619
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
Orsaria P; Chiaravalloti A; Caredda E; Marchese PV; Titka B; Anemona L; Portarena I; Schillaci O; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Dec; 38(12):6639-6652. PubMed ID: 30504372
[TBL] [Abstract][Full Text] [Related]
34. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
35. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
[TBL] [Abstract][Full Text] [Related]
36. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
37. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
38. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Tong SY; Lee JM; Ki KD; Choi YJ; Seol HJ; Lee SK; Huh CY; Kim GY; Lim SJ
Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711
[TBL] [Abstract][Full Text] [Related]
39.
Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
[TBL] [Abstract][Full Text] [Related]
40. False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.
Nawwar AA; Searle J; Hopkins R; Lyburn ID
Clin Nucl Med; 2021 Dec; 46(12):1004-1005. PubMed ID: 33883486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
